Literature DB >> 7915704

Changes in distribution and activity of glutamine synthetase in carbon tetrachloride-induced cirrhosis in the rat: potential role in hyperammonemia.

R Gebhardt1, J Reichen.   

Abstract

Cirrhosis induced in rats by carbon tetrachloride was used to study alterations in the activities and lobular distribution of carbamoylphosphate synthetase and glutamine synthetase. Specific activity of carbamoylphosphate synthetase in cirrhotic subjects was decreased to 70% of controls. Staining was homogeneous within micronodular areas, but varied from area to area and generally showed a decreased intensity. Specific activity of glutamine synthetase and the size of the glutamine synthetase-positive area were decreased to 20% and less of controls. Glutamine synthetase-positive hepatocytes were rare and scattered at the periphery of nodular areas and within fibrous septa, the normal association with the central veins being widely lost. Rarely, complete micronodules showed a slight homogeneous staining for glutamine synthetase. Arginase activity was not affected, whereas glutaminase activity was enhanced by 50%. Serum levels of ammonia were elevated more than 2-fold and those of glutamine by 30%. In contrast, urea levels tended to be slightly diminished. Serum ammonia levels showed a clear negative correlation with the specific activity of glutamine synthetase and the size of the glutamine synthetase-positive area. Furthermore, blood urea levels correlated with the sum of ammonia and glutamine concentrations, but not with each of these substrate concentrations alone. These data suggest that the changes in activity and distribution of glutamine synthetase contribute to hyperammonemia in cirrhosis. Despite a reduced activity of the initial enzyme of the urea cycle, urea synthesis is not diminished accordingly. This may be due to an enhanced flux caused by the elevated blood level of ammonia and an increased hydrolysis of glutamine, because of higher levels of glutaminase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915704

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.

Authors:  Natalia Qvartskhava; Philipp A Lang; Boris Görg; Vitaly I Pozdeev; Marina Pascual Ortiz; Karl S Lang; Hans J Bidmon; Elisabeth Lang; Christina B Leibrock; Diran Herebian; Johannes G Bode; Florian Lang; Dieter Häussinger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

2.  Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice.

Authors:  S Gupta; L K Rogers; S K Taylor; C V Smith
Journal:  Toxicol Appl Pharmacol       Date:  1997-10       Impact factor: 4.219

3.  Effects of L-carnitine in patients with hepatic encephalopathy.

Authors:  Mariano Malaguarnera; Giovanni Pistone; Rampello Elvira; Carmelo Leotta; Linda Scarpello; Rampello Liborio
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

4.  Coexpression of periportal and perivenous enzymes in rat hepatocytes after experimental bile duct ligation: comparison with intrasplenically transplanted hepatocytes.

Authors:  L Racine-Samson; J V Scoazec; A Moreau; L Christa; D Bernuau; G Feldmann
Journal:  Histochem Cell Biol       Date:  1996-04       Impact factor: 4.304

5.  Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis.

Authors:  Lawrence A Scheving; Xiuqi Zhang; David W Threadgill; William E Russell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-01       Impact factor: 4.052

6.  β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation.

Authors:  Jung Min Lee; Jing Yang; Pippa Newell; Sucha Singh; Anil Parwani; Scott L Friedman; Kari Nichole Nejak-Bowen; Satdarshan P Monga
Journal:  Cancer Lett       Date:  2013-09-23       Impact factor: 8.679

7.  Hepatic glutamine synthetase augmentation enhances ammonia detoxification.

Authors:  Leandro R Soria; Matthew Nitzahn; Angela De Angelis; Suhail Khoja; Sergio Attanasio; Patrizia Annunziata; Donna J Palmer; Philip Ng; Gerald S Lipshutz; Nicola Brunetti-Pierri
Journal:  J Inherit Metab Dis       Date:  2019-03-11       Impact factor: 4.982

8.  De novo expression of glutamine synthetase during transformation of hepatic stellate cells into myofibroblast-like cells.

Authors:  J G Bode; T Peters-Regehr; A M Gressner; D Häussinger
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  Effects of a high protein diet and liver disease in an in silico model of human ammonia metabolism.

Authors:  Jeddidiah W D Griffin; Patrick C Bradshaw
Journal:  Theor Biol Med Model       Date:  2019-07-31       Impact factor: 2.432

10.  Keratinocytes as depository of ammonium-inducible glutamine synthetase: age- and anatomy-dependent distribution in human and rat skin.

Authors:  Lusine Danielyan; Sebastian Zellmer; Stefan Sickinger; Genrich V Tolstonog; Jürgen Salvetter; Ali Lourhmati; Dieter D Reissig; Cristoph H Gleiter; Rolf Gebhardt; Gayane Hrachia Buniatian
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.